{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:08:11Z","timestamp":1792670891132,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.healun.2016.12.016","type":"journal-article","created":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T12:31:16Z","timestamp":1483101076000},"page":"380-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices"],"prefix":"10.1016","volume":"36","author":[{"given":"Brian A.","family":"Houston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.C.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joban","family":"Vaishnav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Cromwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Elliott","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil F.","family":"Faridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Sciortino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Whitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Tedford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerin R.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Judge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart D.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanne","family":"Rouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2016.12.016_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/CIR.0b013e318282ab8f","article-title":"Heart disease and stroke statistics\u20142013 update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2016.12.016_bib2","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1161\/CIRCULATIONAHA.110.982512","article-title":"Keeping left ventricular assist device acceleration on track","volume":"123","author":"Stewart","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2016.12.016_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.healun.2014.04.010","article-title":"Sixth INTERMACS annual report: a 10,000-patient database","volume":"33","author":"Kirklin","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.12.016_bib4","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2016.12.016_bib5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jacc.2007.03.063","article-title":"Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial","volume":"50","author":"Rogers","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2016.12.016_bib6","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.jacc.2014.01.053","article-title":"Results of the destination therapy post-Food and Drug Administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support)","volume":"63","author":"Jorde","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2016.12.016_bib7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.healun.2012.02.015","article-title":"Gastrointestinal bleeding with the HeartMate II left ventricular assist device","volume":"31","author":"Morgan","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.12.016_bib8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1540-8191.2010.01025.x","article-title":"Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD","volume":"25","author":"Stern","year":"2012","journal-title":"J Card Surg"},{"key":"10.1016\/j.healun.2016.12.016_bib9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jtcvs.2008.07.032","article-title":"Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices","volume":"137","author":"Crow","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2016.12.016_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.healun.2003.10.018","article-title":"GI bleeding from arterio-venous malformations in patients supported by the Jarvik 2000 axial flow left ventricular assist device","volume":"24","author":"Lestou","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.12.016_bib11","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jacc.2010.05.016","article-title":"Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation","volume":"56","author":"Uriel","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2016.12.016_bib12","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.athoracsur.2011.06.081","article-title":"Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices","volume":"92","author":"John","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2016.12.016_bib13","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.athoracsur.2012.02.035","article-title":"Incidence and management of gastrointestinal bleeding with continuous flow assist devices","volume":"93","author":"Aggarwal","year":"2012","journal-title":"Ann Thoracic Surg"},{"key":"10.1016\/j.healun.2016.12.016_bib14","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2015.07.075","article-title":"Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP study","volume":"66","author":"Estep","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2016.12.016_bib15","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.healun.2011.03.008","article-title":"Arteriovenous malformations and gastrointestinal bleeding in patients with HeartMate II left ventricular assist device","volume":"30","author":"Demirozu","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.12.016_bib16","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1572-0241.1999.01017.x","article-title":"Increased expression of angiogenic factors in human colonic angiodysplasia","volume":"94","author":"Junquera","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.healun.2016.12.016_bib17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1365-2796.2000.00717-2.x","article-title":"Increased plasma vascular endothelial growth factor levels in patients with angiodysplasia","volume":"248","author":"Fujita","year":"2000","journal-title":"J Intern Med"},{"key":"10.1016\/j.healun.2016.12.016_bib18","doi-asserted-by":"crossref","unstructured":"Ahamed J, Monteagudo J, Kinkhabwala M, et al. Patients with end stage congestive heart failure have decreased high molecular weight von Willebrand factor multimers and higher plasma levels of total TGF-\u03b21: implantation of a left ventricular assist devices (LVAD) exacerbates both abnormalities. Oral and poster abstracts presented at: 55th Annual American Society of Hematology Meeting and Exposition. December 7-13, 2013; New Orleans, Louisiana.","DOI":"10.1182\/blood.V122.21.1057.1057"},{"issue":"suppl 2","key":"10.1016\/j.healun.2016.12.016_bib19","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1055\/s-0029-1240709","article-title":"Effect of pulsatile and non-pulsatile left ventricular assist devices on the renin-angiotensin system in patients with end-stage heart failure","volume":"58","author":"Welp","year":"2010","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2016.12.016_bib20","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1182\/blood-2009-01-199166","article-title":"Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells","volume":"114","author":"Shao","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.healun.2016.12.016_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jcp.21706","article-title":"Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis","volume":"219","author":"Ferrari","year":"2009","journal-title":"J Cell Physiol"},{"issue":"6 suppl","key":"10.1016\/j.healun.2016.12.016_bib22","doi-asserted-by":"crossref","first-page":"585S","DOI":"10.1378\/chest.128.6_suppl.585S","article-title":"Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders","volume":"128","author":"Bertolino","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.healun.2016.12.016_bib23","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.CIR.103.6.789","article-title":"Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy","volume":"103","author":"Lim","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2016.12.016_bib24","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1097\/01.hjh.0000182521.44440.c5","article-title":"Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats","volume":"23","author":"Lavoie","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.healun.2016.12.016_bib25","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan\u2019s syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2016.12.016_bib26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/CIRCULATIONAHA.109.883629","article-title":"Transforming growth factor-\u03b2: a biomarker in Marfan syndrome","volume":"120","author":"Braverman","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2016.12.016_bib27","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/ajkd.2000.19078","article-title":"ACE inhibitors attenuate expression of renal transforming growth factor-beta1 in humans","volume":"36","author":"Shin","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.healun.2016.12.016_bib28","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.2337\/dc06-0911","article-title":"Transforming growth factor-beta in human diabetic nephropathy: effects of ACE inhibition","volume":"29","author":"Langham","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.healun.2016.12.016_bib29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000072820","article-title":"Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients","volume":"23","author":"el-Agroudy","year":"2003","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.healun.2016.12.016_bib30","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000069792","article-title":"Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor","volume":"23","author":"Yoshiji","year":"2002","journal-title":"Tumour Biol"},{"key":"10.1016\/j.healun.2016.12.016_bib31","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2337\/diabetes.50.4.867","article-title":"Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells","volume":"50","author":"Otani","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.healun.2016.12.016_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.healun.2013.07.020","article-title":"Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device","volume":"33","author":"Stulak","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.12.016_bib33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/CIRCHEARTFAILURE.112.000206","article-title":"Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II","volume":"6","author":"Wever-Pinzon","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2016.12.016_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/MAT.0000000000000143","article-title":"Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices","volume":"61","author":"Loyaga-Rendon","year":"2015","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2016.12.016_bib35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.healun.2014.09.013","article-title":"Thalidomide for treatment of gastrointestinal angiodysplasia in patients with left ventricular assist devices: case series and treatment protocol","volume":"34","author":"Draper","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.12.016_bib36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.115.019692","article-title":"Elevated angiopoietin-2 level in patients with continuous-flow left ventricular assist devices leads to altered angiogenesis and is associated with higher nonsurgical bleeding","volume":"134","author":"Tabit","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2016.12.016_bib37","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.hfc.2014.07.008","article-title":"The role of heart failure pharmacotherapy after left ventricular assist device support","volume":"10","author":"Rommel","year":"2014","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.healun.2016.12.016_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5301\/ijao.5000068","article-title":"Assessment of the heart failure pharmacotherapy of patients with continuous flow left-ventricular assist devices","volume":"35","author":"Jennings","year":"2012","journal-title":"Int J Artif Organs"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249816304958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249816304958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:33:15Z","timestamp":1760949195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249816304958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1053249816304958"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2016.12.016","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2016.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2017.01.1298","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for the Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}